What are you searching for?

01.07.2020 | Tracker

Top 50 Pharma Tracker: HCPs respond to COVID-19 treatment options

By CREATION.co

Discover what healthcare professionals (HCPs) think about pharmaceutical products and their manufacturers, as it happens, through CREATION.co’s tracking updates. How are HCPs responding to drug launch news? How are HCPs talking about or engaging with the Top 50 pharma companies on social media? Each week CREATION.co’s tracking updates bring you the latest insights from the conversation of HCPs across the globe discussing these topics and more.

June’s Top 50 Pharmaceutical Companies mentioned by HCPs on Twitter, in relation to COVID-19

June
Rank
May
Rank
Company nameTotal
Mentions
Account
mentions
Account
retweets
Number of
accounts
mentioned
11Gilead140222683
26AstraZeneca494140244
33Johnson & Johnson*3011597711
45Sanofi18075618
57GSK13250414
64Pfizer10864306
72Roche1051791
821Regenero1042561
98Novartis7448124
1018Boehringer6564216
1113Menarini6059361
1210Merck & co5849153
1315Lilly53831
1420Fresenius463334
1517Teva393592
169Novo Nordisk302754
1711Takeda3012112
1824CSL2822112
1912Bayer231503
2022BMS202112
2114Abbott1917252
2223AbbVie191502
2325Grifols15000
2419Amgen141353
2532Sun9000
2616Biogen8000
2733Ipsen6551
2835Astellas6000
2927Merck KGaA5101
3037Bausch5000
3126Vertex4401
3230Eisai4201
3339Alexion4301
3431Daiichi-Sankyo3301
3529UCB2101
3636Allergan2000
3738Otsuka2000
3842Stada arzneimittel2221
3928Mylan1000
4043Chugai1000
5034Servier0000
5040Mallinckrodt0000
5041Celgene0000
5050Shire**0000
5050Ferring0000
5050Sumitomo dainippon0000
5050Jiangsu hengrui0000
5050Endo0000
5050Mitsubishi tanabe pharma0000
5050Sino0000

June’s insights from HCPs mentioning the Top 50 Pharmaceutical Companies, in relation to COVID-19

In June 2020, the five pharmaceutical companies that were mentioned the most by HCPs relating to COVID-19 on Twitter were Gilead, AstraZeneca, Johnson and Johnson (J&J), Sanofi and GSK.

Top 50 Pharma discussed online

For a fourth month, Gilead was the most mentioned pharmaceutical company relating to Covid-19. Mentions of Gilead made up 43% of all HCP posts relating to a top 50 Pharma company and Covid-19. Its treatment option, remdesivir, continued to be discussed in over 70% of posts as HCPs reacted to the cost of the product for patients and the price taxpayers had paid for the drug’s R+D. Many HCPs thought it was too expensive, especially during the pandemic.

 

Top 50 Pharma discussed online

https://twitter.com/eugenegu/status/1277587418216988673

Another driver in the conversation was news in Europe with AstraZeneca agreeing to supply their Covid-19 vaccine to EU citizens in their joint venture with Oxford, which HCPs shared positively.

CREATION.co continues to analyse online HCP conversation on a variety of topics including virtual congress, healthcare changes since the pandemic, product development and therapy area specific insights.

To stay up to date, you can sign up to CREATION.co’s monthly eJournal.

  • In June 2020, CREATION Pinpoint® identified 3,273 healthcare professional (HCP) authored tweets about Covid-19 from 2,149 individual HCPs mentioning a top-50 pharmaceutical company (according to revenue). 
  • Data for this research was analysed from the online Twitter conversations of HCPs in relation to Covid-19 in all languages mentioning a Top 50 pharmaceutical company between June 1st and June 30th 2020.
  • Unless otherwise specified, mentions of a company are not limited to its Twitter account(s).
  • In some cases, a tweet may mention more than one company account (eg. @abbottnews and @abbottglobal) – this only counts as one Company Mention but two Account Mentions.
  • The Number of Twitter Accounts Mentioned only include those accounts mentioned by HCPs.
  • * Johnson & Johnson was included as a whole, encompassing its pharmaceutical subsidiary, Janssen. In June, 22 of these posts mentioned Janssen.
  • ** Whilst included in the Top 50 Pharma list according to revenue from 2019, Shire has since been acquired by Takeda and no longer holds a Twitter account.

The Top 50 Pharma tracker archive

View all articles >

Meet the Author

CREATION.co

Suggested next


02.04.2021 | Article

Top 50 Pharma Tracker: Oxford-AstraZeneca vaccine provokes HCP conversation as they discuss blood clots as a side effect.

Discover what healthcare professionals (HCPs) think about Top 50 pharmaceutical companies

By Maria Aguirre

25.09.2020 | Article

HCPs look to neurotech to solve patient treatment challenges

Healthcare professionals are looking to Neurotech to solve patient's treatment challenges

By Adam Doggett

View all articles >